'RE:fine drugs': an interactive dashboard to access drug repurposing opportunities

Soheil Moosavinasab, Jeremy Patterson, Robert Strouse, Majid Rastegar-Mojarad, Kelly Regan, Philip R.O. Payne, Yungui Huang, Simon M. Lin

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost and fast FDA approval. Here, we introduce 'RE:fine Drugs', a freely available interactive website for integrated search and discovery of drug repurposing candidates from GWAS and PheWAS repurposing datasets constructed using previously reported methods in Nature Biotechnology. 'RE:fine Drugs' demonstrates the possibilities to identify and prioritize novelty of candidates for drug repurposing based on the theory of transitive Drug-Gene-Disease triads. This public website provides a starting point for research, industry, clinical and regulatory communities to accelerate the investigation and validation of new therapeutic use of old drugs.Database URL: http://drug-repurposing.nationwidechildrens.org.

Original languageEnglish
JournalDatabase : the journal of biological databases and curation
Volume2016
DOIs
StatePublished - 2016

Fingerprint Dive into the research topics of ''RE:fine drugs': an interactive dashboard to access drug repurposing opportunities'. Together they form a unique fingerprint.

Cite this